BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
|
Back to Search Results |
|
Model Number 24653 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Thrombosis (2100); Claudication (2550); Arteriosclerosis/ Atherosclerosis (4437); Thrombosis/Thrombus (4440)
|
Event Date 11/08/2018 |
Event Type
Injury
|
Event Description
|
Eminent clinical study.It was reported that in-stent thrombosis occurred.The patient was enrolled in the eminent clinical study with the patient identifier of (b)(6).On (b)(6) 2018, the index procedure was performed.The target lesion was located in the right mid distal superficial femoral artery (sfa).The target lesion had a reference vessel diameter of 6mm, both distally and proximally, was 148mm long, and was 100% stenosed.A 6mm x 120mm eluvia stent and a 6mm x 80mm eluvia stent were implanted in the sfa.Post-dilatation was performed using two dilatation balloons, and residual stenosis was 15%.No thrombus was seen in the treated vessel at the end of the procedure.On (b)(6) 2018, the patient was hospitalized.On (b)(6) 2018, a ct scan was performed and in-stent thrombosis was detected in the upper part of both stents.An interventional procedure is scheduled for (b)(6) 2018.
|
|
Manufacturer Narrative
|
Device is a combination product.
|
|
Event Description
|
Eminent clinical study.It was reported that in-stent thrombosis occurred.The patient was enrolled in the eminent clinical study with the patient identifier of (b)(4).On (b)(6) 2018, the index procedure was performed.The target lesion was located in the right mid distal superficial femoral artery (sfa).The target lesion had a reference vessel diameter of 6mm, both distally and proximally, was 148mm long, and was 100% stenosed.A 6mm x 120mm eluvia stent and a 6mm x 80mm eluvia stent were implanted in the sfa.Post-dilatation was performed using two dilatation balloons, and residual stenosis was 15%.No thrombus was seen in the treated vessel at the end of the procedure.On (b)(6) 2018, the patient was hospitalized.On (b)(6) 2018, a ct scan was performed and in-stent thrombosis was detected in the upper part of both stents.An interventional procedure is scheduled for (b)(6) 2018.It was further reported that the patient was treated with a right "fempop (fp3)" bypass procedure on (b)(6) 2018.The event is considered to be resolved.
|
|
Event Description
|
Eminent clinical study.It was reported that in-stent thrombosis occurred.The patient was enrolled in the eminent clinical study with the patient identifier of (b)(6).On (b)(6) 2018, the index procedure was performed.The target lesion was located in the right mid distal superficial femoral artery (sfa).The target lesion had a reference vessel diameter of 6mm, both distally and proximally, was 148mm long, and was 100% stenosed.A 6mm x 120mm eluvia stent and a 6mm x 80mm eluvia stent were implanted in the sfa.Post-dilatation was performed using two dilatation balloons, and residual stenosis was 15%.No thrombus was seen in the treated vessel at the end of the procedure.On (b)(6) 2018, the patient was hospitalized.On (b)(6) 2018, a ct scan was performed and in-stent thrombosis was detected in the upper part of both stents.An interventional procedure is scheduled for (b)(6) 2018.It was further reported that the patient was treated with a right "fempop (fp3)" bypass procedure on (b)(6) 2018.The event is considered to be resolved.It was further reported that on (b)(6) 2018 the patient presented with complaints of being bedridden for two weeks post index procedure due to right thigh pain.There was persistent claudication, more in the right leg than left leg and pain persisted after walking for about approximately 50 meters.Duplex examination revealed occlusion of the stent in the right sfa.On (b)(6) 2018, the ct angiography of the pelvic arteries- upper leg arteries scanned in arterial phase of right limb revealed complete occlusion of superficial femoral artery, a few centimeters post-ostial, reinjection distally in the popliteal artery, stent in the middle third to distally with only retrograde opacification in the distal stent section was noted.Ct angiography of the pelvic arteries- upper leg arteries scanned in arterial phase of left limb sfa revealed severe atherosclerotic damage with very fragile caliber in the proximal third, followed by complete occlusion.Collateral reinjection distally with limited retrograde opacification in the distal stent section was noted.Due to the findings of early in-stent thrombosis five weeks post index procedure and in view of the patient's symptoms, femoropopliteal bypass was suggested.On (b)(6) 2018, the patient was hospitalized for the planned treatment.Rutherford classification of claudication was assessed as 3 (severe claudication).On (b)(6) 2018, iliofemoral interposition graft and femoropopliteal bypass (p3) was performed in the right leg to treat this event.The event was considered resolved and the subject was discharged in a good condition on aspirin and clopidogrel.
|
|
Event Description
|
Eminent clinical study.It was reported that in-stent thrombosis occurred.The patient was enrolled in the eminent clinical study with the patient identifier of (b)(6).On (b)(6), 2018, the index procedure was performed.The target lesion was located in the right mid distal superficial femoral artery (sfa).The target lesion had a reference vessel diameter of 6mm, both distally and proximally, was 148mm long, and was 100% stenosed.A 6mm x 120mm eluvia stent and a 6mm x 80mm eluvia stent were implanted in the sfa.Post-dilatation was performed using two dilatation balloons, and residual stenosis was 15%.No thrombus was seen in the treated vessel at the end of the procedure.On (b)(6) 2018, the patient was hospitalized.On (b)(6) 2018, a ct scan was performed and in-stent thrombosis was detected in the upper part of both stents.An interventional procedure is scheduled for (b)(6), 2018.It was further reported that the patient was treated with a right "fempop (fp3)" bypass procedure on (b)(6) 2018.The event is considered to be resolved.It was further reported that on (b)(6) 2018 the patient presented with complaints of being bedridden for two weeks post index procedure due to right thigh pain.There was persistent claudication, more in the right leg than left leg and pain persisted after walking for about approximately 50 meters.Duplex examination revealed occlusion of the stent in the right sfa.On (b)(6) 2018, the ct angiography of the pelvic arteries- upper leg arteries scanned in arterial phase of right limb revealed complete occlusion of superficial femoral artery, a few centimeters post-ostial, reinjection distally in the popliteal artery, stent in the middle third to distally with only retrograde opacification in the distal stent section was noted.Ct angiography of the pelvic arteries- upper leg arteries scanned in arterial phase of left limb sfa revealed severe atherosclerotic damage with very fragile caliber in the proximal third, followed by complete occlusion.Collateral reinjection distally with limited retrograde opacification in the distal stent section was noted.Due to the findings of early in-stent thrombosis five weeks post index procedure and in view of the patient's symptoms, femoropopliteal bypass was suggested.On (b)(6) 2018, the patient was hospitalized for the planned treatment.Rutherford classification of claudication was assessed as 3 (severe claudication).On (b)(6) 2018, iliofemoral interposition graft and femoropopliteal bypass (p3) was performed in the right leg to treat this event.The event was considered resolved and the subject was discharged in a good condition on aspirin and clopidogrel.It was further reported that on (b)(6) 2018 when the p3 procedure was performed, the lesion was 100% stenosed with a reference vessel diameter of 6mm and 40mm length mid- to distal sfa.Post procedure residual stenosis was 0% with absence of thrombus.
|
|
Search Alerts/Recalls
|
|
|